TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY - CORCEPT THERAPEUTICS INC ownership

CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 206 filers reported holding CORCEPT THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.52 and the average weighting 0.1%.

Quarter-by-quarter ownership
TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY ownership history of CORCEPT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$844
+22.5%
30,9570.0%0.01%
+28.6%
Q2 2023$689
+8.7%
30,957
+5.7%
0.01%
+16.7%
Q1 2023$634
+6.6%
29,2830.0%0.01%0.0%
Q4 2022$595
-99.9%
29,283
-6.6%
0.01%
-33.3%
Q3 2022$804,000
+20.5%
31,356
+5.8%
0.01%
+50.0%
Q1 2022$667,000
+13.6%
29,6340.0%0.01%
+20.0%
Q4 2021$587,000
+0.7%
29,6340.0%0.01%0.0%
Q3 2021$583,000
-10.6%
29,6340.0%0.01%
-16.7%
Q2 2021$652,000
-7.5%
29,6340.0%0.01%
-14.3%
Q1 2021$705,000
-14.9%
29,634
-6.3%
0.01%
-12.5%
Q4 2020$828,000
+50.3%
31,6340.0%0.01%
+33.3%
Q3 2020$551,000
+3.6%
31,6340.0%0.01%0.0%
Q2 2020$532,000
+41.5%
31,6340.0%0.01%
+20.0%
Q1 2020$376,000
-6.0%
31,634
-4.2%
0.01%
+25.0%
Q4 2019$400,000
-14.3%
33,0340.0%0.00%
-33.3%
Q3 2019$467,000
+26.9%
33,0340.0%0.01%
+50.0%
Q2 2019$368,000
-5.2%
33,0340.0%0.00%
-20.0%
Q1 2019$388,000
-12.0%
33,0340.0%0.01%
-16.7%
Q4 2018$441,000
-4.8%
33,0340.0%0.01%0.0%
Q3 2018$463,000
-13.9%
33,034
-3.5%
0.01%0.0%
Q2 2018$538,000
-4.4%
34,2340.0%0.01%
-14.3%
Q1 2018$563,000
+82.2%
34,234
+100.2%
0.01%
+75.0%
Q4 2017$309,00017,1000.00%
Other shareholders
CORCEPT THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
INGALLS & SNYDER LLC 8,609,429$55,961,0003.12%
INVESTOR AB 1,835,974$11,934,0000.86%
GLOBEFLEX CAPITAL L P 244,183$1,587,0000.40%
Campbell & CO Investment Adviser LLC 21,446$139,0000.37%
Birchview Capital, LP 80,000$520,0000.30%
FEDERATED HERMES, INC. 13,879,968$90,220,0000.26%
MENTA CAPITAL LLC 388,582$2,526,0000.24%
Sitrin Capital Management LLC 40,000$260,0000.20%
ESSEX INVESTMENT MANAGEMENT CO LLC 172,389$1,121,0000.18%
GSA CAPITAL PARTNERS LLP 384,976$2,502,0000.13%
View complete list of CORCEPT THERAPEUTICS INC shareholders